lobbying_activities: 2505955

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2505955	577d01be-624e-41c3-b32c-74c826a4774b	Q3	HOLLAND & KNIGHT LLP	18466	NOVEOME BIOTHERAPEUTICS	2020	third_quarter	MED	Pending clinical issues before the FDA; COVID-19 pandemic related issues before Congress and the Development Finance Corporation.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2020-10-11T13:16:20.627000-04:00